TGen

This #ColorectalCancer Awareness Month, Lance Bass is helping highlight why colorectal cancer screening matters and how early detection can save lives, especially as rates continue to rise among younger adults. Learn more: bit.ly/40wyejv

Cancer is ever evolving and changing, and researchers need technology that can help answer their questions. At TGen, part of City of Hope, not only are our scientists using the latest technology to better understand disorders, but they are also creating the #technology.

Improving cancer detection and treatment doesn't happen alone. TGen is proud to partner with physician-scientists at City of Hope to continue to improve outcomes for all patients. #YoungerFacesofCancer #ColorectalCancer

March is #MyelomaActionMonth Dr. Joe Mikhael, professor at TGen, shares how TGen is working to improve patient care for those diagnosed with #MultipleMyeloma. #TGen #Research

TGen is committed to educating and inspiring future scientists 🧬 Tyler Izatt shared about his journey to becoming a #bioinformatician, his current projects at TGen, and the future of the field. #EducationOutreach #TGen #Arizona

2026 marks the 20th anniversary of the partnership between TGen and Helios Education Foundation. Dr. Amanda Courtright-Lim, 2018 alum, shares how this program pushed her to think outside the box and push for greater impact. #TGen #Helios #Internship #Impact

City of Hope recently shared their predictions for cancer research & care in 2026. Kamel Lahouel, Ph.D., assistant professor in theEarly Detection and Prevention Division, shared how AI is a tool for expanding the quality of care. Predictions List @ bit.ly/3YAsUL1

At TGen, part of @cityofhope, we are working to bring life-changing solutions directly to the patient's bedside. We are committed to #precisionmedicine. We want to help patients receive personalized care - the right care, for the right patient, at the right time.

City of Hope recently shared their predictions for cancer research and care in 2026. Keehoon Lee, Ph.D., shared his perspective on the work being done to study the microbiome and how it may improve outcomes. Read the full list of predictions at: bit.ly/3YAsUL1

Behind every breakthrough, discovery, and innovation is a dual engine: world-class research and seamless operational support. ⚙️🔬 Huge shoutout to the strategists, coordinators, planners and technology who keep the lab lights on and the vision moving forward.

City of Hope recently shared their predictions for cancer research and care in 2026. Aleksandar Sekulic, M.D., Ph.D., physician-in-chief, TGen, shared his perspective on the unique opportunity of working alongside each other - lab bench to patient bedside. bit.ly/3YAsUL1

A new preclinical study offers encouraging evidence that combining an FDA-approved cancer drug, arsenic trioxide (ATO), w/ an investigational MNK1 inhibitor, AUM001, may help overcome one of the greatest challenges in treating GBM: resistance to therapy. bit.ly/4k9eTxy

In honor of Dr. Martin Luther King, Jr.'s "I Have a Dream " speech, we ask our colleagues what their dreams were as kids (and what they are today!). Whether it’s a career milestone, or a personal hobby, we are proud of our colleagues and what they are working to achieve ✨

It may be a new year, but at TGen we are continuing to work towards our mission of conducting groundbreaking research with life-changing results. Be sure to follow along as we share updates on leading-edge research and innovative breakthroughs. 🧬🔬🥼🧫🧪

✨1️⃣✨ Pinpointing Where Molecular Changes Begin: A study uncovered important molecular signatures that could help predict the progression of hepatic steatosis, a liver condition linked to obesity and other metabolic disorders. Click to read the story: 🔗 bit.ly/3DpGgCj

2️⃣ Blood-based test detects precancerous colorectal lesions. A study details promising ways to detect adenomas (precancerous polyps) using cell-free DNA from a simple liquid biopsy (a blood test). Read more at: 🔗 bit.ly/3M0t8I9

3️⃣ New hope for lung cancer patients: A study reports on a potential therapeutic strategy that uses the body’s own natural killer (NK) cells to fight hard-to-treat lung cancers. Read the full story here: 🔗 bit.ly/44tyQZp

4️⃣ A Spatial Map of Gene Expression in Pulmonary Fibrosis: Published in Nature Genetics, revealing hidden disease markers in seemingly healthy lung tissue through advanced spatial transcriptomics. 🔗 Link to podcast: tgen.org/tgen-talks/epi… #PulmonaryFibrosis #Research #TGen

5️⃣ Could “Zombie” Cells Offer New Hope for Pancreatic Cancer Treatment? TGen’s work on a new treatment approach for pancreatic ductal adenocarcinoma (PDAC), a highly aggressive cancer with just a 13% five-year survival rate. Read the full story at: 🔗 bit.ly/3WZeZOa

6️⃣ AI Breakthrough in Cancer Genomics. Developed by @ucscgenomics & @googleresearch, with contributions from TGen's Dr. Floris Barthel, the tool enhances identification of somatic variants — mutations acquired during life that often fuel tumor growth. 🔗bit.ly/4nYDDJY